Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kaori Daimaru"'
Autor:
Yosuke Osuka, Narumi Kojima, Kaori Daimaru, Risa Ono, Masamitsu Sugie, Takuya Omura, Keiko Motokawa, Takuya Ueda, Kazushi Maruo, Toshihiko Aoyama, Shigeru Inoue, Hiroyuki Sasai
Publikováno v:
Journal of Epidemiology, Vol 34, Iss 10, Pp 467-476 (2024)
Background: Radio-Taiso, a long-standing exercise program in Japan, could be a sustainable public health strategy for maintaining quality of life (QoL) in older adults with frailty. This study aimed to investigate whether Radio-Taiso provided greater
Externí odkaz:
https://doaj.org/article/80e627c1f8774ea690394a87e24e95e3
Publikováno v:
BMC Research Notes, Vol 15, Iss 1, Pp 1-6 (2022)
Abstract Objective Hearing loss is an important public health problem. Its causes vary, including infections, noise, and aging. The first wave of the COVID-19 pandemic occurred in April 2020 in Japan. During the pandemic, people were urged to stay at
Externí odkaz:
https://doaj.org/article/8ab105b171ec46a388cb18735c0da90a
Autor:
Kaori Daimaru, Yukiko Wagatsuma
Publikováno v:
PLoS ONE, Vol 17, Iss 10, p e0275877 (2022)
ObjectiveHearing loss is a major public health concern. Higher physical function may be related to the maintenance of hearing acuity. Therefore, this study examined the association between hearing loss and physical function in the general population.
Externí odkaz:
https://doaj.org/article/19b2e24bf9ba4f7daf4fd0e7a83d4456
Publikováno v:
The Journal of Rheumatology. 42:712-722
Objective.To identify macrophage activation syndrome (MAS) in patients with systemic juvenile idiopathic arthritis (sJIA) undergoing tocilizumab (TCZ) treatment, and to confirm laboratory marker changes and responses to treatment in patients with MAS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::243db27f4f1e3f7e395aeb3f1d08f90a
https://doi.org/10.3899/jrheum.140288
https://doi.org/10.3899/jrheum.140288
Autor:
Kaori Daimaru, Kosaku Fujiwara, Itaru Yamaguchi, Hisako Murakami, Akitoshi Ichimura, Akiko Murata
Publikováno v:
Journal of Toxicologic Pathology. 10:157-164
The effect of hypertriglyceridemia was examined on streptozotocin (STZ)-induced diabetic nephropathy in rats. After repeated intraperitoneal injection with Triton WR- 1339 (Triton) in STZ-diabetic rats, food and water consumption and urine volume wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d6094058dbdc125cb3949978c3d16e6
https://doi.org/10.1293/tox.10.157
https://doi.org/10.1293/tox.10.157
Autor:
Kosaku Fujiwara, Itaru Yamaguchi, Akitoshi Ichimura, Hisako Murakami, Akiko Murata, Kaori Daimaru
Publikováno v:
Journal of Toxicologic Pathology. 9:341-350
The effect of hypercholesterolemia on diabetic nephropathy was studied in rats fed with or without cholesterol (CHS) for 112 days after intraperitoneal injection of 50 mg/kg streptozotocin (STZ). Serum cholesterol was increased only in STZ-diabetic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::face08ff0347788b029cce32616cd0d5
https://doi.org/10.1293/tox.9.341
https://doi.org/10.1293/tox.9.341
Autor:
Angelo Ravelli, Syuji Takei, Sheila Weitzman, Kaori Daimaru, Fabrizio De Benedetti, R. Schneider, Clare Devlin, Shumpei Yokota
Publikováno v:
Arthritis & Rheumatology. 66:S83-S84
Background/Purpose: Macrophage activation syndrome (MAS) is a severe, potentially fatal complication of systemic juvenile idiopathic arthritis (sJIA).[1] Changes in therapies, including biologics,[2, 3] may trigger MAS. Interleukin-6 (IL-6) plays a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6a90373f63e590468ecddcb34c6070c
https://doi.org/10.1002/art.38472
https://doi.org/10.1002/art.38472
Publikováno v:
Journal of Rheumatology; Apr2015, Vol. 42 Issue 4, p712-722, 11p
Autor:
R. Schneider, Sheila Weitzman, Angelo Ravelli, Clare Devlin, Syuji Takei, Shumpei Yokota, Kaori Daimaru, Fabrizio De Benedetti
Publikováno v:
Pediatric Rheumatology Online Journal
Macrophage activation syndrome (MAS) is a severe, potentially fatal complication of systemic juvenile idiopathic arthritis (sJIA). Changes in therapies, including biologics, have been associated with the onset of MAS. Interleukin-6 (IL-6) plays a maj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fdff7a02f9152f76c2723b59e7ff4d9